Demonstration of -V600E in Rosai-Dorfman-Destombes disease requires sensitive molecular assays and molecular-based tissue immunostain. -V600E blood testing is important for disease-monitoring -mutated histiocytosis and can guide inhibitor treatment plans.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595264 | PMC |
http://dx.doi.org/10.1182/bloodadvances.2019000093 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!